-
UM researcher uses stem cells to fight Alzheimer’s
The promise of Neuralstem’s neural stem cell platform technology to treat neurodegenerative disorders, including ALS and Alzheimer’s disease, is the focus of this feature story on the clinical and pre-clinical work underway by NSI-566/ALS principal investigator, Eva L. Feldman, MD, PhD and her team at University of Michigan. “When you get something that works so beautifully (like this experiment), you can quickly see its translational potential. I am looking at a mouse but some day I could be looking at a man. As a clinician scientist, those are the moments you live for,” Dr. Feldman said, regarding her team’s study transplanting Neuralstem’s NSI-532.IGF cells in an animal model of Alzheimer’s disease, with data presented in October at The Congress of Neurological Surgeons Annual Meeting.
